These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35544484)

  • 1. The Unique Magnetic Signature of Sickle Red Blood Cells: A Comparison Between the Red Blood Cells of Transfused and Non-Transfused Sickle Cell Disease Patients and Healthy Donors.
    Weigand M; Gomez-Pastora J; Strayer J; Wu X; Choe H; Lu S; Plencner E; Landes K; Palmer A; Zborowski M; Desai P; Chalmers J
    IEEE Trans Biomed Eng; 2022 Dec; 69(12):3582-3590. PubMed ID: 35544484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
    Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
    Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
    J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetophoretic and spectral characterization of oxyhemoglobin and deoxyhemoglobin: Chemical versus enzymatic processes.
    Weigand MRH; Gómez-Pastora J; Kim J; Kurek MT; Hickey RJ; Irwin DC; Buehler PW; Zborowski M; Palmer AF; Chalmers JJ
    PLoS One; 2021; 16(9):e0257061. PubMed ID: 34478473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism.
    Culp-Hill R; Srinivasan AJ; Gehrke S; Kamyszek R; Ansari A; Shah N; Welsby I; D'Alessandro A
    Transfusion; 2018 Dec; 58(12):2797-2806. PubMed ID: 30265764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell mechanical sensitivity improves in patients with sickle cell disease undergoing chronic transfusion after prolonged, subhemolytic shear exposure.
    Simmonds MJ; Suriany S; Ponce D; Detterich JA
    Transfusion; 2018 Dec; 58(12):2788-2796. PubMed ID: 30325033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size and density measurements of single sickle red blood cells using microfluidic magnetic levitation.
    Goreke U; Bode A; Yaman S; Gurkan UA; Durmus NG
    Lab Chip; 2022 Feb; 22(4):683-696. PubMed ID: 35094036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.
    Nakagawa A; Ferrari M; Schleifer G; Cooper MK; Liu C; Yu B; Berra L; Klings ES; Safo RS; Chen Q; Musayev FN; Safo MK; Abdulmalik O; Bloch DB; Zapol WM
    Mol Pharm; 2018 May; 15(5):1954-1963. PubMed ID: 29634905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired erythrocyte methemoglobin reduction in sickle cell disease: dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content.
    Zerez CR; Lachant NA; Tanaka KR
    Blood; 1990 Sep; 76(5):1008-14. PubMed ID: 2393709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical calculation of lifespan of transfused RBCs in sickle cell disease patients.
    Kim J; Usmani A; De Simone N; Sarode R
    Transfus Apher Sci; 2018 Feb; 57(1):46-49. PubMed ID: 29196100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling.
    Bourgeaux V; Hequet O; Campion Y; Delcambre G; Chevrier AM; Rigal D; Godfrin Y
    Transfusion; 2010 Oct; 50(10):2176-84. PubMed ID: 20456710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.
    Moriconi C; Dzieciatkowska M; Roy M; D'Alessandro A; Roingeard P; Lee JY; Gibb DR; Tredicine M; McGill MA; Qiu A; La Carpia F; Francis RO; Hod EA; Thomas T; Picard M; Akpan IJ; Luckey CJ; Zimring JC; Spitalnik SL; Hudson KE
    Br J Haematol; 2022 Aug; 198(3):574-586. PubMed ID: 35670632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction.
    D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Gordeuk VR; Gladwin MT
    Am J Hematol; 2023 Jul; 98(7):1017-1028. PubMed ID: 36971592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
    Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC
    Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Evaluation of Allosteric Effectors for Hemoglobin.
    Enakaya NA; Jefferson A; Chew-Martinez D; Matthews JS
    Acc Chem Res; 2023 Jun; 56(11):1279-1286. PubMed ID: 36946781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease.
    Jagadeeswaran R; Vazquez BA; Thiruppathi M; Ganesh BB; Ibanez V; Cui S; Engel JD; Diamond AM; Molokie RE; DeSimone J; Lavelle D; Rivers A
    Exp Hematol; 2017 Jun; 50():46-52. PubMed ID: 28238805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined computational and experimental investigation of the filtration function of splenic macrophages in sickle cell disease.
    Li G; Qiang Y; Li H; Li X; Buffet PA; Dao M; Karniadakis GE
    PLoS Comput Biol; 2023 Dec; 19(12):e1011223. PubMed ID: 38091361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and β-Thalassemia: A biotin label approach.
    Gerritsma JJ; van der Bolt N; van Bruggen R; Ten Brinke A; van Dam J; Guerrero G; Vermeulen C; de Bruin S; Vlaar APJ; Biemond BJ; Nur E; van der Schoot E; Fijnvandraat K;
    Transfusion; 2022 Oct; 62(10):1984-1996. PubMed ID: 35916478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dense red blood cell and oxygen desaturation in sickle-cell disease.
    Di Liberto G; Kiger L; Marden MC; Boyer L; Poitrine FC; Conti M; Rakotoson MG; Habibi A; Khorgami S; Vingert B; Maitre B; Galacteros F; Pirenne F; Bartolucci P
    Am J Hematol; 2016 Oct; 91(10):1008-13. PubMed ID: 27380930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.